In a massive push to turn India pharma-independent, the central government has sanctioned 48 new projects under the PLI scheme to increase domestic production of essential drug ingredients called APIs and KSMs...
In a significant boost to the biopharma sector, the Indian Council of Medical Research (ICMR) has issued an Expressions of Interest (EoI) to license its indigenous malaria vaccine, AdFalciVax. The vaccine targets Plasmodium falciparum...
The Department of Biotechnology (DBT) has released a flagship program for establishing a countrywide network of artificial intelligence
India saved ?1,362 crore in pharma raw material imports due to strategic investment under the PLI Scheme for Bulk Drugs, the government told Parliament on Tuesday.
In an important development demonstrating confidence in the global healthcare sector of India, Abu Dhabi Investment Authority (ADIA) has completed a definitive investment agreement for USD 200 million in Meril, a high-quality medical device company..
Hailing from one of Eastern India's oldest surviving Ayurvedic families
In a significant advancement in areas of adult and geriatric care, Akums Drugs & Pharmaceuticals Ltd. has released India's first high-strength paracetamol oral suspension at 500mg/5ml, establishing a new model for the country's pharmaceutical...
In a significant step to enhance its natural health portfolio, SuanNutra Group's European distribution division Gonmisol has signed an exclusive distribution agreement with Indian-based K Patel Phyto Extractions...
Roche faced a regulatory setback today as the U.S. FDA issued a Complete Response Letter (CRL) for its bid to expand Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for certain DLBCL patients...
India's burgeoning heart disease burden is not only seen in melodramatized reports of cardiac arrests of young heroes but also in a frightening 50% five-year jump in sales of cardiovascular medicines.